ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 761

$559K Total Retail Price of All Prescriptions

Rank: 90 out of 761

645 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 645 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

15% of this provider’s 645 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,969 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 495 359 S3 1 5
SIMVASTATIN 395 383 2 2
AMLODIPINE BESYLATE 392 355 3 6
LISINOPRIL 380 326 4 1
PRAVASTATIN SODIUM 369 321 5 20
LEVOTHYROXINE SODIUM 365 324 6 3
OMEPRAZOLE 337 271 7 4
ATENOLOL 329 296 8 8
FUROSEMIDE 326 306 9 7
HYDROCHLOROTHIAZIDE 308 286 10 11
WARFARIN SODIUM 190 190 11 9
POTASSIUM CHLORIDE 184 177 12 18
METFORMIN HCL 183 151 13 10
ATORVASTATIN CALCIUM 183 157 13 12
CITALOPRAM HBR 180 122 15 19
METOPROLOL TARTRATE 174 150 16 14
TRAZODONE HCL 161 125 17 23
LOSARTAN POTASSIUM 161 145 17 13
SERTRALINE HCL 159 129 19 25
MIRTAZAPINE 137 137 20 50
MORPHINE SULFATE ER 133 46 S2 21 38
LOVASTATIN 133 127 21 17
OXYCODONE HCL 124 57 S2 23 24
PROAIR HFA 118 97 24 32
ZOLPIDEM TARTRATE 117 97 25 22
METFORMIN HCL ER 115 106 26 67
LANTUS 112 79 27 41
GLIPIZIDE 108 108 28 39
TAMSULOSIN HCL 102 95 29 27
METOPROLOL SUCCINATE 99 99 30 16
GABAPENTIN 92 75 31 15
CYMBALTA 89 35 32 53
ISOSORBIDE MONONITRATE ER 80 76 33 72
ALENDRONATE SODIUM 80 80 33 21
DONEPEZIL HCL 79 79 35 33
KLOR-CON 10 70 65 36 74
PANTOPRAZOLE SODIUM 69 47 37 40
INSULIN SYRINGE 68 41 38 78
PROMETHAZINE HCL 67 18 R 39 104
FAMOTIDINE 66 47 40 60
FELODIPINE ER 64 64 41 108
FLUTICASONE PROPIONATE 63 55 42 29
LEVOXYL 61 59 43 96
OXYCODONE-ACETAMINOPHEN 61 30 S2 43 49
CYCLOBENZAPRINE HCL 57 33 R 45 51
TRIAMCINOLONE ACETONIDE 57 52 45 84
KLOR-CON M20 56 56 47 99
POLYETHYLENE GLYCOL 3350 56 41 47 62
CIPROFLOXACIN HCL 56 52 47 63
TRICOR 55 51 50 164
NAPROXEN 54 18 51 105
BENAZEPRIL HCL 54 54 51 112
AZITHROMYCIN 53 33 53 70
CARVEDILOL 52 52 54 26
DIGOXIN 51 51 55 43
ENALAPRIL MALEATE 50 50 56 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.